Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab.
Zhang F, Qi X, Wang X, Wei D, Wu J, Feng L, Cai H, Wang Y, Zeng N, Xu T, Zhou A, Zheng Y.
Zhang F, et al.
Oncotarget. 2017 Oct 6;8(52):90215-90224. doi: 10.18632/oncotarget.21652. eCollection 2017 Oct 27.
Oncotarget. 2017.
PMID: 29163822
Free PMC article.